免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Anthogyr AXIOM® BL X3植入物,Anthogyr Multi-Unit元件用於AXIOM® BL

K 號:K230104 · 2023-10-16

申請人Anthogyr
決定日期2023-10-16
產品代碼DZE
諮詢委員會DE
決定相當於

器材摘要

Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL is the device name listed in this FDA 510(k) record. The listed applicant is Anthogyr. It received FDA 510(k) clearance on 2023-10-16 under 510(k) number K230104. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL?

Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL is a medical device that received FDA 510(k) clearance on 2023-10-16. The listed applicant is Anthogyr. The 510(k) number is K230104.

When did Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL receive FDA 510(k) clearance?

Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL received FDA 510(k) clearance on 2023-10-16, under 510(k) number K230104.

Who is the listed applicant for Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL?

The FDA 510(k) record lists Anthogyr as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL?

The FDA product code for Anthogyr AXIOM® BL X3 implants, Anthogyr Multi-Unit components for AXIOM® BL is DZE.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Anthogyr 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DZE)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑